Snapshot from Jun 09, 2026 at 07:00 UTC. For live data and tracking: View Live
Events / Regulatory / Gossamer Bio Securities Fraud Lawsuit
Regulatory class action lawsuit

Gossamer Bio Securities Fraud Lawsuit

Analysis based on 10 articles · First reported May 18, 2026 · Last updated May 28, 2026

Sentiment
-60
Attention
4
Articles
10
Market Impact
Direct
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The class action lawsuit against Gossamer Bio is likely to negatively impact its stock price due to legal costs and potential damages. Investors who purchased shares during the Class Period may recover losses, while The_The Schall Law Firm stands to gain from successful litigation.

Biotechnology Legal Services
Event Summary

The The Schall Law Firm has initiated a class action lawsuit against Gossamer Bio, a publicly traded company, for alleged violations of securities laws. The lawsuit claims that Gossamer Bio made false and misleading statements to the market between June 16, 2025, and February 20, 2026, concerning the design of its Phase 3 PROSERA study. Specifically, the complaint alleges that Gossamer Bio concealed adverse facts regarding controls for placebo response at certain testing sites. Investors who suffered losses during this 'Class Period' are encouraged to join the lawsuit before June 1, 2026. Brian Schall of The_The Schall Law Firm is leading the effort to represent affected shareholders.

Key Actions
100 The Schall Law Firm filed class action lawsuit Gossamer Bio
90 Gossamer Bio made false statements
Entities Involved
stock
Gossamer Bio
Gossamer Bio is the defendant in a class action lawsuit for allegedly making false and misleading statements regarding its Phase 3 PROSERA study, leading to investor losses.
Importance 100 Sentiment -70
priv
The Schall Law Firm
The The Schall Law Firm is initiating and representing investors in a class action lawsuit against Gossamer Bio, seeking to recover losses for shareholders.
Importance 80 Sentiment 50
per
Brian Schall
Brian Schall is an attorney at The The Schall Law Firm and is encouraging investors to contact the firm to participate in the class action lawsuit against Gossamer Bio.
Importance 60 Sentiment 40
govactor
United States — United States Securities and Exchange Commission
The class action lawsuit against Gossamer Bio is for violations of regulations promulgated by the United States — United States Securities and Exchange Commission.
Importance 20 Sentiment 0
NEWSDESK
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.